Published online 7 January 2005
Article |
Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides
Medical Research Council, Laboratory of Molecular Biology Hills Road, Cambridge CB2 2QH, UK
*To whom correspondence should be addressed. Tel: +44 1223 248011; Fax: +44 1223 402070; Email: mgait{at}mrc-lmb.cam.ac.uk
Received November 4, 2004. Revised December 1, 2004. Accepted December 1, 2004.
Oligonucleotides composed of 2'-O-methyl and locked nucleic acid residues complementary to HIV-1 trans-activation responsive element TAR block Tat-dependent trans-activation in a HeLa cell assay when delivered by cationic lipids. We describe an improved procedure for synthesis and purification under highly denaturing conditions of 5'-disulphide-linked conjugates of 3'-fluorescein labelled oligonucleotides with a range of cell-penetrating peptides and investigate their abilities to enter HeLa cells and block trans-activation. Free uptake of 12mer OMe/LNA oligonucleotide conjugates to Tat (4858), Penetratin and R9F2 was observed in cytosolic compartments of HeLa cells. Uptake of the Tat conjugate was enhanced by N-terminal addition of four Lys or Arg residues or a second Tat peptide. None of the conjugates entered the nucleus or inhibited trans-activation when freely delivered, but inhibition was obtained in the presence of cationic lipids. Nuclear exclusion was seen for free delivery of Tat (4858), Penetratin and R9 conjugates of 16mer phosphorothioate OMe oligonucleotide. Uptake into human fibroblast cytosolic compartments was seen for Tat, Penetratin, R9F2 and Transportan conjugates. Large enhancements of HeLa cell uptake into cytosolic compartments were seen when free Tat peptide was added to Tat conjugate of 12mer OMe/LNA oligonucleotide or Penetratin peptide to Penetratin conjugate of the same oligonucleotide.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Juliano, Md. R. Alam, V. Dixit, and H. Kang Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides Nucleic Acids Res., July 1, 2008; 36(12): 4158 - 4171. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Tacken, B. Joosten, A. Reddy, D. Wu, A. Eek, P. Laverman, A. Kretz-Rommel, G. J. Adema, R. Torensma, and C. G. Figdor No Advantage of Cell-Penetrating Peptides over Receptor-Specific Antibodies in Targeting Antigen to Human Dendritic Cells for Cross-Presentation J. Immunol., June 1, 2008; 180(11): 7687 - 7696. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Alam, V. Dixit, H. Kang, Z.-B. Li, X. Chen, J. Trejo, M. Fisher, and R. L. Juliano Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis Nucleic Acids Res., May 1, 2008; 36(8): 2764 - 2776. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dow-Tien, T. Yuan-Jhih, and L. Alan Creating a ribonuclease T-tat that preferentially recognizes and hydrolyzes HIV-1 TAR RNA in vitro and in vivo Nucleic Acids Res., February 11, 2008; 36(3): 963 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Fabani and M. J. Gait miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates RNA, February 1, 2008; 14(2): 336 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gogoi, M. V. Mane, S. S. Kunte, and V. A. Kumar A versatile method for the preparation of conjugates of peptides with DNA/PNA/analog by employing chemo-selective click reaction in water Nucleic Acids Res., December 18, 2007; 35(21): e139 - e139. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lundberg, S. El-Andaloussi, T. Sutlu, H. Johansson, and U. Langel Delivery of short interfering RNA using endosomolytic cell-penetrating peptides FASEB J, September 1, 2007; 21(11): 2664 - 2671. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Abes, J. J. Turner, G. D. Ivanova, D. Owen, D. Williams, A. Arzumanov, P. Clair, M. J. Gait, and B. Lebleu Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide Nucleic Acids Res., July 26, 2007; 35(13): 4495 - 4502. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Veldhoen, S. D. Laufer, A. Trampe, and T. Restle Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect Nucleic Acids Res., December 2, 2006; 34(22): 6561 - 6573. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. IVANOVA, A. A ARZUMANOV, J. J TURNER, S. REIGADAS, J.-J. TOULME, D. E BROWN, A. M.L LEVER, and M. J GAIT Anti-HIV Activity of Steric Block Oligonucleotides Ann. N.Y. Acad. Sci., October 1, 2006; 1082(1): 103 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Marchan, S. Ortega, D. Pulido, E. Pedroso, and A. Grandas Diels-Alder cycloadditions in water for the straightforward preparation of peptide-oligonucleotide conjugates Nucleic Acids Res., February 14, 2006; 34(3): e24 - e24. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Turner, G. D. Ivanova, B. Verbeure, D. Williams, A. A. Arzumanov, S. Abes, B. Lebleu, and M. J. Gait Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells Nucleic Acids Res., November 30, 2005; 33(21): 6837 - 6849. [Abstract] [Full Text] [PDF] |
||||




